Hindustan Times 2014.05.19 10:34
AP New York, May 19, 2014
The board of directors of British drug maker AstraZeneca on Monday rejected
the raised $119 billion takeover offer from US drugmaker Pfizer.
AstraZeneca's board said in a statement it "reiterates its confidence in
AstraZeneca's ability to deliver on its prospects as an independent,
science led business."
Pfizer Inc., the world's second-biggest drugmaker by revenue, has been
PFIZER, PROSPECT, OFFER, BOARD, TAKEOVER, CLOSURE, Read, Johnson, Johansson, Pfizer Inc., Lambert Co., Pharmacia Corp., USA, United Kingdom, India, Швейцария, Canada